PHILOGENE INC

Owner

Goods & Services

Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes,and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of progression of cancer renal diseases CNS disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in urology; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma

Development of new technology for others in the field of antiangiogenic drugs and of diseases treatable by the administration of drugs that have the cytoprotective neuroprotective cell survival properties of the VEGF family of molecules; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development

Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields